Welcome to the new Gustave Roussy website
A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.
A new Big Data research team at Gustave Roussy
Winner of the Cancer Research Foundation's "Tomorrow's Leaders in Oncology" call for projects, Sergey Nikolaev, big data expert internationnally renowned, will put a team together at Gustave Roussy and implement his research project.
Published on
Changed on
Winner of the Cancer Research Foundation's "Tomorrow's Leaders in Oncology" call for projects, Sergey Nikolaev, big data expert internationnally renowned, will put a team together at Gustave Roussy and implement his research project.
The arrival of Sergey Nikolaev, will boost Gustave Roussy's ambition to explore new therapeutic avenues in data analysis, by developing predictive models concerning response, resistance or relapse to treatment. His research is obviously beneficial to Gustave Roussy, endowing it with the critical expertise so essential to speeding research into the genetic mutations that cause cancer and to developing new treatments. Being based at Gustave Roussy, he benefits from an outstanding research environment with direct access to the big data banks.
Sergey Nikolaev won a PhD in Molecular Biology in Moscow (Russia), then spent 13 years at the University of Geneva (Switzerland), two of them as head of the clinical bioinformatics department dealing with tumor sequencing. He has written several international publications including features in the major journals such as Nature Genetics, Nature Communication or the New England Journal of Medicine.
- For more informations, read the press release
Last news
-
Breast Cancer: Gustave Roussy Ranked No. 1 in France for Breast Surgery and Breast Reconstruction
On the occasion of Breast Cancer Awareness Month, the 2025 data from Visuchir, the national surgical activity monitoring tool of the French Health Insurance system, places Gustave Roussy in first position for both breast surgery and breast reconstruction. Beyond this ranking, these figures highlight that reconstruction is now an integral part of breast cancer treatment. It is considered at every stage of care: from tumor removal surgery, whether lumpectomy or mastectomy, through to the post-cancer period, helping to restore the body and support women in regaining their physical integrity and quality of life.
-
Newsweek Ranking: Gustave Roussy Named Europe’s Leading Cancer Centre and Third Best Worldwide
The 2027 edition of Newsweek’s World's Best Specialized Hospitals ranking once again recognises Gustave Roussy as the leading cancer centre in France and Europe, and the third best worldwide. This distinction highlights the excellence of the Institute’s care and research, as well as the daily commitment of all its professionals.
-
Living with and beyond cancer: the promises and challenges of digital health
In a Viewpoint article published in The Lancet Digital Health, Drs Ines Vaz-Luis and Maria Alice Franzoi, together with Emmanuel Mussault, a patient partner at the PRISM University Hospital Institute, examine the role that digital tools can play in supporting people living with and beyond cancer. Their central message is that these technologies can support more personalised and accessible care, but their value depends primarily on how they are integrated into care pathways, the human support provided, their ability to address individual needs and their evaluation in real-world settings.
-
Gustave Roussy and The Lancet launch an international lecture series on innovations transforming cancer care
The inaugural lecture in the “Lecture Series on Cancer Breakthroughs” will take place on Friday 18 September at 5:00 pm. It will be delivered by Professor Timothy R. Rebbeck, a leading cancer prevention specialist at Harvard University and the Dana-Farber Cancer Institute.
